文献速递白血病

外周血原始细胞清除率是急性髓系白血病临床反应与结局的独立预测因素

Peripheral blood blast rate of clearance is an independent predictor of clinical response and outcomes in acute myeloid leukaemia.
PubMed 文献 · Br J Haematol · 2019-12-05

该研究纳入164例初治且诊断时外周血可检测到原始细胞的AML患者,均接受蒽环类联合阿糖胞苷(7+3)诱导化疗,计算外周血原始细胞清除率(PBB-RC)。结果显示PBB-RC每增加5%,D14骨髓清除、完全缓解(CR)和总生存(OS)均显著改善;非洲裔美国患者调整PBB-RC后OS更差。

核心结论

  • 诱导化疗期间外周血原始细胞清除率可预测D14骨髓清除、CR和OS,可作为AML预后标志物。

研究设计与样本

  • 回顾性分析164例初治AML患者,均接受蒽环类联合阿糖胞苷(7+3)诱导化疗,且诊断时外周血可检测到原始细胞。

关键数值与推荐

  • PBB-RC定义为诊断当天的外周血原始细胞绝对计数中,平均每日治疗清除的百分比,直至第14天或PBB清除日。

临床怎么用

  • PBB-RC可作为诱导化疗早期评估化疗敏感性和预后的指标,辅助临床决策。

局限性

  • 研究为单中心回顾性分析,样本量有限,需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The day 14 bone marrow aspirate and biopsy (D14BM) is regularly used to predict achievement of complete remission (CR) with induction chemotherapy in acute myeloid leukemia (AML), however its utility has been questioned. Clearance of peripheral blood blasts (PBB) may serve as an early measure of chemosensitivity. PBB rate of clearance (PBB-RC) was calculated for treatment-naive AML patients (n = 164) undergoing induction with an anthracycline and cytarabine (7+3) and with detectable PBB at diagnosis. PBB-RC was defined as the percentage of the absolute PBB count on the day of diagnosis that was cleared with each day of therapy, on average, until D14 or day of PBB clearance. Each 5% increase in PBB-RC approximately doubled the likelihood of D14BM clearance (OR = 1·81; 95% CI: 1·24-2·64, P < 0·005). PBB-RC was also associated with improved CR rates (OR per 5% = 1·97; 95% CI: 1·27-3·01, P < 0·005) and overall survival (OS) [hazard ratio (HR) per 5% = 0·67; 95% CI: 0·52-0·87]. African American patients had poorer OS adjusted for PBB-RC (HR = 2·18; 95% CI: 1·13-4·23), while race was not associated with D14BM or CR rate. PBB-RC during induction chemotherapy is predictive of D14BM clearance, CR, and OS, and can therefore serve as a prognostic marker for clinical outcomes in AML.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Holtzman NG, El Chaer F, Baer MR, et al. Peripheral blood blast rate of clearance is an independent predictor of clinical response and outcomes in acute myeloid leukaemia. Br J Haematol. 2019. PMID: 31804722. doi:10.1111/bjh.16261

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。